Bipolar Depression: Pregnancy, Postpartum, and Lactation.

Loading...

Date

2016-03

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

60
views
225
downloads

Citation Stats

Attention Stats

Abstract

Medication management of bipolar depression in pregnancy and lactation is best done by assessing each patient's and family's needs in detail. Keeping pregnant patients as psychiatrically stable as possible is the most important principle for clinicians. Unfortunately, there is no risk-free situation for patients with psychiatric illness. This is often the most difficult and hard to accept reality for these patients, families, and clinicians. Clinicians serve these patients best by being as transparent as possible about the risk/benefit analysis of each patient's situation with the realization that ultimately the decisions are made by the patient and family.

Department

Description

Provenance

Subjects

Humans, Pregnancy Complications, Depression, Postpartum, Antipsychotic Agents, Antidepressive Agents, Teratogens, Risk Factors, Bipolar Disorder, Lactation, Pregnancy, Female

Citation

Published Version (Please cite this version)

10.1016/j.psc.2015.10.002

Publication Info

Wald, Marla F, Andrew J Muzyk and Drue Clark (2016). Bipolar Depression: Pregnancy, Postpartum, and Lactation. The Psychiatric clinics of North America, 39(1). pp. 57–74. 10.1016/j.psc.2015.10.002 Retrieved from https://hdl.handle.net/10161/25083.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Scholars@Duke

Wald

Marla F. Wald

Associate Professor of Psychiatry and Behavioral Sciences
Muzyk

Andrew Muzyk

Associate Professor of the Practice of Medical Education

Dr. Andrew Muzyk is an Associate Professor of the Practice of Medical Education at Duke University School of Medicine and an Associate Professor in the Department of Pharmacy Practice at Campbell University College of Pharmacy and Health Sciences. He also holds a Clinical Associate appointment in the Duke University School of Nursing. His professional responsibilities span teaching across multiple health professions programs, serving as a clinical pharmacist on the Medicine–Psychiatry service at Duke University Hospital, and advancing scholarship in health professions education and clinical outcomes research.

Teaching
At Duke University School of Medicine, Dr. Muzyk directs pharmacology content and serves as course director for the Foundations of Patient Care II course, which integrates pharmacology, pathology, microbiology, immunology, and clinical medicine, in the first-year medical school curriculum. He lectures extensively in the first-year medical student curriculum, focusing on central nervous system pharmacology, and previously directed the Biological Psychiatry course for Duke psychiatry residents.

At Campbell University, he teaches pharmacotherapy with an emphasis on psychiatric and substance use disorders, men’s health, and neurology–psychiatry. He co-coordinates the Pharmacoepidemiology and Health Informatics modules and precepts pharmacy students in internal medicine and psychiatry clerkships at Duke University Hospital. Beyond these roles, he contributes to physician assistant, nursing, osteopathic medicine, and other health professions programs at Duke and Campbell, and he mentors graduate students in the University of Michigan’s Master of Health Professions Education program.

Clinical Practice
Dr. Muzyk practices as a clinical pharmacist in the Duke University Hospital Department of Pharmacy. He rounds on the Medicine–Psychiatry inpatient service and provides consultative expertise to the inpatient psychiatry unit and the opioid use disorder consult service.

Scholarship
Dr. Muzyk has authored more than 70 peer-reviewed publications addressing health professions education, psychopharmacology, and hospital-based medication outcomes. His research has appeared in journals such as Academic Medicine, Substance Abuse, Psychosomatics, Academic Psychiatry, American Journal of Pharmaceutical Education, CNS Drugs, and Pharmacotherapy. He has secured over $200,000 in research and educational funding, including support from the National Institute on Drug Abuse, Duke Academy for Health Professions Education and Academic Development, Duke Division of Addiction Medicine, Duke Bass Connections, the Josiah Charles Trent Memorial Foundation, and Campbell University. He is a frequent national speaker on psychiatric and substance use disorders and interprofessional education and regularly lectures for the North Carolina Area Health Education Centers.

Awards
Dr. Muzyk’s contributions have been recognized with numerous honors, including the Dean’s Award for Excellence in Teaching and Educator of the Year from Campbell University, the Association of American Medical Colleges Curricular Innovation Award, the Association for Multidisciplinary Education and Research in Substance Use and Addiction New Educator/Investigator Award, the Duke University Hospital Educator and Researcher of the Year Award, the Duke AHEAD Interprofessional Excellence Award, the Association of Academic Psychiatry Psychiatric Education Award, and the North Carolina Association of Pharmacists Distinguished Young Pharmacist Award.

Education and Training
Dr. Muzyk earned his PharmD from Mercer University College of Pharmacy and completed two years of residency training, culminating in a psychiatric pharmacy residency at UNC Medical Center. He received his Master of Health Professions Education from the University of Michigan and completed the Climate Health Organizing Fellowship through Harvard Medical School and Cambridge Health Alliance.


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.